Adient (NYSE:ADNT - Get Free Report) had its price objective hoisted by research analysts at UBS Group from $25.00 to $26.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. UBS Group's price objective would indicate a potential upside of 18.70% from the company's previous close.
ADNT has been the subject of several other reports. Citigroup initiated coverage on Adient in a report on Wednesday, April 23rd. They issued a "neutral" rating and a $14.00 price objective for the company. Barclays raised their price objective on shares of Adient from $18.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 16th. Wells Fargo & Company lifted their price objective on shares of Adient from $17.00 to $18.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 1st. Morgan Stanley dropped their price objective on shares of Adient from $17.00 to $16.00 and set an "underweight" rating on the stock in a report on Monday, May 19th. Finally, Bank of America upped their target price on shares of Adient from $15.00 to $17.50 and gave the stock an "underperform" rating in a research report on Monday, June 16th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.94.
Read Our Latest Stock Report on ADNT
Adient Stock Performance
NYSE:ADNT traded down $0.09 during mid-day trading on Thursday, reaching $21.90. 1,128,388 shares of the stock were exchanged, compared to its average volume of 1,460,022. The company has a 50 day simple moving average of $20.50 and a 200-day simple moving average of $16.58. Adient has a 1 year low of $10.04 and a 1 year high of $24.25. The stock has a market capitalization of $1.78 billion, a P/E ratio of -8.27, a P/E/G ratio of 0.78 and a beta of 1.72. The company has a quick ratio of 0.92, a current ratio of 1.12 and a debt-to-equity ratio of 1.15.
Adient (NYSE:ADNT - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $3.74 billion for the quarter, compared to analysts' expectations of $3.56 billion. Adient had a positive return on equity of 8.25% and a negative net margin of 1.53%. The business's quarterly revenue was up .7% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 EPS. Analysts anticipate that Adient will post 1.76 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Adient
Several institutional investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. increased its position in shares of Adient by 96.5% in the fourth quarter. JPMorgan Chase & Co. now owns 802,540 shares of the company's stock worth $13,828,000 after purchasing an additional 394,111 shares during the last quarter. Northern Trust Corp raised its position in shares of Adient by 6.8% in the 4th quarter. Northern Trust Corp now owns 1,129,645 shares of the company's stock worth $19,464,000 after purchasing an additional 72,077 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Adient during the 1st quarter valued at about $1,036,000. Man Group plc bought a new stake in shares of Adient during the 4th quarter valued at about $704,000. Finally, SG Americas Securities LLC bought a new position in shares of Adient during the 1st quarter valued at approximately $601,000. Institutional investors own 92.44% of the company's stock.
Adient Company Profile
(
Get Free Report)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories

Before you consider Adient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.
While Adient currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.